0001140361-25-012826.txt : 20250408 0001140361-25-012826.hdr.sgml : 20250408 20250408160602 ACCESSION NUMBER: 0001140361-25-012826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250404 FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ondrey Aaron CENTRAL INDEX KEY: 0001991078 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36829 FILM NUMBER: 25821969 MAIL ADDRESS: STREET 1: 9 CEDARBROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001281895 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 BUSINESS PHONE: 646-440-9100 MAIL ADDRESS: STREET 1: 350 FIFTH AVENUE STREET 2: SUITE 7530 CITY: NEW YORK STATE: NY ZIP: 10118 FORMER COMPANY: FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20040226 4 1 form4.xml FORM 4 X0508 4 2025-04-04 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001991078 Ondrey Aaron C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true Chief Financial Officer false Common Stock 2025-04-04 4 S 0 7489 5.294 D 129650 D Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. /s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey 2025-04-08